Drug Combinations and New Approvals Delivering Optimistic Results in Oncology Stocks

VANCOUVER, BC: VANCOUVER, BC, Dec. 8, 2021 /PRNewswire/ -- USA News Group - Growing at a healthy CAGR of 14.1%, the Cancer Immunotherapy Market is being projected to hit nearly $310 billion by 2030, according to Allied Analytics. Over the past decade, cancer drug revenues increased 70%, according to a...

Click to view original post